Village Farms Commends Trump for Rescheduling Marijuana to Schedule III
Village Farms commended U.S. President Donald Trump for his executive order directing the Attorney General to reschedule marijuana to a Schedule III drug under the Controlled Substances Act. Michael DeGiglio, founder, president, CEO of Village Farms commented, "We commend President Trump for his efforts to overcome decades of policy failures and bureaucratic red tape to advance meaningful reform that will help improve the lives of millions of Americans. We look forward to a better future in the United States in which federal cannabis policy follows scientific and medical research to unlock a new wave of investment and innovation in cannabinoid-based therapeutic products. Earlier this year, Village Farms' legal strategy in the DEA hearing process sought to prevent a failure to reschedule cannabis. We had a unique opportunity to represent our industry in the ALJ proceedings, and we're proud that our actions and advocacy efforts helped contribute to President Trump's thoughtful, evidenced based approach to enacting federal reform. We remain committed to collaborating with policymakers to advance commonsense reform for our seniors, military warriors, veterans, and medical patients, and believe our CBDistillery e-commerce platform, operational capabilities and U.S. production assets can help support increasing demand for safe, affordable medical cannabis products."
Trade with 70% Backtested Accuracy
Analyst Views on VFF
About VFF
About the author

- Conference Call Announcement: Village Farms will host a conference call on March 12, 2026, at 8:30 a.m. ET to discuss its Q4 and full-year 2025 financial results, with a news release expected prior to the call to enhance investor transparency.
- Diverse Participation Options: Participants can join the call via webcast or telephone registration, with telephone participants required to register in advance to receive dial-in information, ensuring smooth and timely communication.
- Q&A Session Limitations: While the Q&A session is limited to analysts, other participants can submit questions via email beforehand, and management will address these during the call as time permits, reflecting the company's commitment to investor feedback.
- International Market Expansion: Village Farms is actively expanding in international markets, planning to export medical cannabis from its EU GMP certified facility in Canada to countries like Germany and the UK, showcasing the company's growth potential and strategic positioning in the global cannabis market.
- Loan Commitment Increase: On February 20, 2026, Village Farms amended its Canadian cannabis credit facility by upsizing loan commitments by CAD 15 million and extending maturities to February 2029, demonstrating the company's flexibility in financing and strong credit profile.
- Financing Structure Optimization: The incremental debt financing is structured as a delayed draw term loan, with an initial draw of CAD 5 million, while all other loan terms remain unchanged, with variable interest rates currently below 6.0%, providing low-cost capital for future growth investments.
- Strategic Growth Support: CEO Michael DeGiglio emphasized that this financing reflects Village Farms' strong credit image and ongoing market leadership, enhancing the company's competitive advantage while preserving significant optionality for future organic and acquisitive growth opportunities.
- International Market Expansion: Village Farms plans to leverage its existing assets in the U.S. and international markets to further expand its cannabis business, particularly in countries like Germany, the UK, and Australia, enhancing its competitiveness in the global market through this financing.
- New Product Launch: Village Farms International, Inc. (VFF) has introduced ten new cannabis product lines in the Netherlands through its wholly-owned subsidiary Leli Holland, leveraging consumer insights and operational expertise from legal cannabis markets worldwide to enhance its competitive edge.
- Market Positioning Strategy: The new product portfolio emphasizes specific consumption occasions and format innovation, carefully considering the demands of the Dutch legacy market, which demonstrates the company's strategic approach to product development aimed at meeting local consumer expectations.
- Export Sales Growth: As of September 30, 2025, Village Farms' export sales surged by 758% year-over-year, supported by its EU GMP-certified operations within a 4.8 million square foot production facility, ensuring its competitiveness in highly regulated global medical markets.
- Industry Recognition: Village Farms was awarded the Consumer Products category at the 2026 BC Export Awards, further solidifying its leadership position in the agriculture and cannabis sectors, reflecting the company's strong performance and potential for future growth.
- Outstanding Export Performance: Village Farms has been awarded the Consumer Products category at the 2026 BC Export Awards, highlighting its exceptional contribution to international trade and economic growth in British Columbia.
- Significant Sales Growth: As of September 30, 2025, the company achieved a 758% year-over-year increase in export sales, a testament to its disciplined, market-specific growth strategies and regulatory compliance expertise, showcasing its competitiveness in highly regulated markets.
- International Market Expansion: Village Farms exports medical cannabis to several international markets, including Germany, the UK, and Israel, through its EU-GMP certified operations, demonstrating its strong influence and growth potential in the global market.
- Solid Local Foundation: As one of the largest single-site agricultural employers in British Columbia, the company continues to invest locally, ensuring the consistency and high quality of its products in international markets, further solidifying its global competitiveness.
- Analyst Rating Upgrades: As earnings season begins, low-to-mid cap consumer staples stocks like The Andersons (ANDE) and Beyond Meat (BYND) have received an A+ EPS revision rating from analysts, indicating growing confidence in their profitability outlook.
- Improved Earnings Expectations: Companies such as Freshpet (FRPT) and John B. Sanfilippo & Son (JBSS) have shown strong performance in recent earnings estimate upgrades, suggesting an improvement in their fundamentals.
- Increased Market Attention: Firms like Oddity Tech (ODD) and Reynolds Consumer Products (REYN) are attracting investor interest due to their strong earnings momentum, with positive analyst revisions likely to drive stock price increases.
- Industry Trend Analysis: Companies such as Turning Point Brands (TPB) and Village Farms International (VFF) are performing well in the current market environment, demonstrating resilience in the consumer staples sector amid structural challenges.
- Momentum Score Surge: The AdvisorShares Pure U.S. Cannabis ETF's momentum score skyrocketed from 24.75 to 88.95 in just over a week, reflecting strong market confidence in the cannabis sector, particularly following the Trump administration's policy shift to reclassify marijuana, which is expected to significantly enhance industry profitability.
- Profitability Enhancement: The reclassification allows companies like Tilray Brands Inc. to deduct standard business expenses, unlocking substantial cash flows that further drive investor interest in related stocks, contributing to a rally among the ETF's constituents in the new year.
- New Subsidiary Launch: Tilray has established Tilray Medical USA as its new medical subsidiary in response to the government's reclassification, aiming to tap into the “research-oriented national medical cannabis industry,” which will open new revenue streams and enhance market competitiveness.
- Favorable Market Trends: The AdvisorShares Cannabis ETF exhibits favorable price trends across short, medium, and long-term horizons, reflecting optimistic investor expectations for the future development of the cannabis industry, thereby solidifying its significance in investment portfolios.







